Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No racial disparities in prostate cancer-specific mortality after biochemical recurrence following radical prostatectomy or radiation therapy.

Prostate cancer and prostatic diseasesĀ·2026
Same author

External validation of the European association of urology biochemical recurrence risk groups to predict mortality after radical prostatectomy or radiation therapy in a North American cohort.

BJUI compassĀ·2026
Same author

SpatialCell AI achieves reference-free single-cell resolution from spot-based spatial transcriptomics through morphology-guided enhancement.

Scientific reportsĀ·2026
Same author

Urine PD-L1 as a non-invasive biomarker for immune checkpoint inhibitor (ICI) therapy in bladder cancer.

Advances in biomarker sciences and technologyĀ·2026
Same author

NCCN GuidelinesĀ® Insights: Prostate Cancer, Version 5.2026.

Journal of the National Comprehensive Cancer Network : JNCCNĀ·2026
Same author

Hepatocellular Carcinoma Bridging and Downstaging: Advances in Locoregional Therapy.

BiomedicinesĀ·2026

Related Experiment Video

Updated: Jun 23, 2025

A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation
09:23

A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation

Published on: February 13, 2017

8.5K

Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research.

Abdalla Elbialy1,2, Deepthi Kappala1, Dhruv Desai1

  • 1OSU Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

Cells
|June 26, 2024
PubMed
Summary

Conditional reprogramming (CR) cultivates patient-derived prostate cancer (PCa) cells, mimicking disease pathophysiology. This approach aids in understanding PCa initiation, progression, and developing targeted therapies.

Keywords:
CRPCapatient-derived cells

More Related Videos

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
08:03

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

Published on: October 20, 2015

14.1K
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

7.0K

Related Experiment Videos

Last Updated: Jun 23, 2025

A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation
09:23

A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation

Published on: February 13, 2017

8.5K
Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
08:03

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

Published on: October 20, 2015

14.1K
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

7.0K

Area of Science:

  • Oncology
  • Cell Biology
  • Translational Research

Background:

  • Prostate cancer (PCa) is a leading cause of cancer mortality in men, with metastatic and recurrent forms presenting significant therapeutic challenges.
  • Conventional PCa cell lines inadequately represent the complex molecular mechanisms of carcinogenesis, limiting therapeutic development.
  • Patient-derived primary cell cultures are crucial for understanding individual PCa pathophysiology and advancing translational research.

Purpose of the Study:

  • To review the applications of the conditional reprogramming (CR) cell culture technique for cultivating patient-derived normal and tumor cells.
  • To highlight how CR recapitulates prostate cancer pathophysiology and aids in identifying novel therapeutics.
  • To discuss the utility of CR cells in understanding PCa initiation, progression, metastasis, and advancing personalized medicine.

Main Methods:

  • Conditional reprogramming (CR) strategy to rapidly cultivate patient-derived normal and tumor cells.
  • CR facilitates the acquisition of stem cell properties in primary cells, mirroring human PCa pathophysiology.
  • Integration of CR cells with tumor organoids and patient-derived xenografts (PDXs) for comprehensive cancer modeling.

Main Results:

  • CR enables effective cultivation of patient-derived prostate cancer cells, preserving their unique pathophysiological characteristics.
  • The CR approach aids in elucidating the molecular pathogenesis of PCa, including initiation, progression, and metastasis.
  • CR models, alongside organoids and PDXs, are instrumental in NCI initiatives like PDMR and HCMI.

Conclusions:

  • Conditional reprogramming is a powerful tool for generating patient-derived prostate cancer models that accurately reflect human disease.
  • CR facilitates a deeper understanding of PCa biology, enabling the discovery of new treatment strategies and personalized medicine approaches.
  • The combination of CR, organoids, and PDXs offers a robust platform for advancing precision oncology in prostate cancer research.